Qiagen Reports 13 Percent Q3 Revenue Growth on Strong Molecular Dx Sales

The company also reported that its profit rose 81 percent for the quarter. Revenues and net income both exceeded guidance provided by the company in Q2.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.